Intact calcium signaling in adrenergic-deficient embryonic mouse hearts

Jessica N Peoples1, David G Taylor1, Alexander N Katchman2

  • 1Burnett School of Biomedical Sciences, Division of Metabolic and Cardiovascular Sciences, College of Medicine, University of Central Florida, 6900 Lake Nona Blvd, Orlando, FL 32827, United States.

Insights

Embryonic mouse hearts lacking adrenergic hormones survive due to intact calcium signaling. This research shows that adrenergic deficiency doesn't impair cardiac calcium signaling, suggesting it's not the cause of heart failure in these embryos.

Area of Science:

  • Cardiovascular Physiology
  • Developmental Biology
  • Molecular Cardiology

Background:

  • Adrenergic hormones, norepinephrine (NE) and epinephrine (EPI), are vital for cardiac function.
  • Deficiencies in cardiac calcium signaling are linked to heart failure.
  • Dbh-/- mouse embryos lack NE and EPI, leading to embryonic lethality from heart failure around E10.5.

Purpose of the Study:

  • To investigate if adrenergic deficiency in embryonic mouse hearts causes impaired cardiac calcium signaling before the onset of heart failure.
  • To determine the role of adrenergic hormones in the development of embryonic cardiac calcium signaling.

Main Methods:

  • Ratiometric fluorescent calcium imaging to measure cytosolic calcium transients ([Ca2+]i) in isolated E10.5 mouse hearts.
  • Stimulation with extracellular calcium, caffeine, and NE.
  • Immunofluorescent histochemical staining for calcium channel distribution.
  • Patch-clamp recording to assess L-type calcium current (ICa,L) activity.

Main Results:

  • Spontaneous [Ca2+]i oscillations were present and responded normally to stimuli in adrenergic-deficient hearts.
  • Distribution and activity of the L-type calcium channel (ICa,L) were similar in both deficient and control embryonic hearts.
  • Intracellular and extracellular calcium signaling pathways were functional in E10.5 adrenergic-deficient hearts.

Conclusions:

  • Adrenergic hormones are not essential for the development of functional intracellular calcium oscillations or extracellular calcium signaling via ICa,L in embryonic hearts.
  • Aberrant calcium signaling is unlikely to be the primary cause of heart failure in Dbh-/- mouse embryos.
  • Cardiac development and function can proceed without adrenergic signaling up to E10.5.

Related Concept Videos

Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
2.0K
Adrenergic Neurons: Neurotransmission01:27

Adrenergic Neurons: Neurotransmission

Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which...
5.4K
Adrenergic Agonists: Therapeutic Classification01:18

Adrenergic Agonists: Therapeutic Classification

Adrenergic agonists can be classified based on their therapeutic uses and mechanisms of action. They serve various purposes in clinical applications.
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
1.7K
Anatomy of the Heart01:27

Anatomy of the Heart

The human heart is made up of three layers of tissue that are surrounded by the pericardium, a membrane that protects and confines the heart. The outermost layer, closest to the pericardium, is the epicardium. The pericardial cavity separates the pericardium from the epicardium. Beneath the epicardium is the myocardium, the middle layer, and the endocardium, the innermost layer. There are four chambers of the heart: the right atrium, the right ventricle, the left atrium, and the left ventricle.
120.7K
Cell-surface Signaling01:21

Cell-surface Signaling

Hormones—or any molecule that binds to a receptor, known as a ligand—that are lipid-insoluble (water-soluble) are not able to diffuse across the cell membrane. In order to be able to affect a cell without entering it, these hormones bind to receptors on the cell membrane. When a first messenger, a hormone, binds to a receptor, a signal cascade is set off, causing second messengers, proteins inside the cell, to become activated, resulting in downstream effects.
54.9K
Adrenergic Receptors (Adrenoceptors): Classification01:27

Adrenergic Receptors (Adrenoceptors): Classification

Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
5.1K